Topics

ESMO 2019: The case for biosimilar use in oncology, clarifying concepts and allaying fears

07:51 EDT 3 Oct 2019 | Pharmaceutical Technology

A ‘special session’ during the first day of the European Society for Medical Oncology conference (ESMO 2019) highlighted evidence demonstrating...
Read More...

The post ESMO 2019: The case for biosimilar use in oncology, clarifying concepts and allaying fears appeared first on Pharmaceutical Technology.

Original Article: ESMO 2019: The case for biosimilar use in oncology, clarifying concepts and allaying fears

NEXT ARTICLE

More From BioPortfolio on "ESMO 2019: The case for biosimilar use in oncology, clarifying concepts and allaying fears"

Quick Search

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...